After Kim completed her Master Thesis in 2024 she returned to the Lab in July to join the GRK2381. Her project is focused on harnessing the cGMP pathway for CAR T cell therapy to improve the therapeutic efficacy of cellular immunotherapies. We are very happy to be part of the GRK2381 and appreciate the very collaborative exchange and are excited for the next years. đâš
As part of a science slam event Kim achieved the third place pitching her project. #KimPossibleđ„
Timo Hinnenthal and Zoi Laspa won the first and second place. Congratulations!
Comentarios